Supplements in the News
|Soy Isoflavones Lower Postmenopausal CVD Risk|
|Published Thursday, December 1, 2005|
England--High intake of soy may reduce levels of C-reactive protein
(CRP) in postmenopausal women, thereby reducing their risk of
developing cardiovascular disease (CVD), according to a study published
in the American Journal of Clinical Nutrition (82, 6:1260-68, 2005).
A multi-national European research team conducted a randomized, double blind, placebo-controlled, crossover dietary intervention trial on 117 healthy postmenopausal European women. For eight weeks, the women consumed cereal bars enriched with 50 mg soy isoflavones, with a genistein-to-daidzein ratio of 2-to-1, or placebo cereal bars, with a washout period of eight weeks before crossover. Plasma inflammatory biomarkers were measured at baseline and eight weeks of each study arm. Isoflavones improved CRP concentrations compared with placebo, but had no significant effects on other plasma inflammatory markers.
The researchers concluded isoflavones have beneficial effects on CRP concentrations, but not on other inflammatory biomarkers of cardiovascular disease risk in postmenopausal women.
These abstracts provided courtesy of Natural Products Industry Insider, published by Virgo Publishing Inc.
To learn more about these dietary supplements and others, including research citations, information on basic use, dosage, and contraindications, written in layman's terms, visit the DSIB Web site at www.supplementinfo.org. Finding the information is as easy as clicking on the name of a supplement or condition.
Send this page to a friend |  Show Other Stories